Danaher
JP Morgan Healthcare Conference Day 2: Labcorp, Thermo Fisher Scientific, Abbott, Danaher, More
Highlights of the second day included Labcorp's update on its COVID-19 testing trends and Ortho Clinical's perspective on its proposed acquisition by Quidel.Â
Danaher, PerkinElmer, Cue Health, Others Announce Preliminary Q4 Earnings Results
Other companies reporting preliminary Q4 financial results included Fluidigm, SomaLogic, and T2 Biosystems.
In Brief This Week: Roche, Veracyte, Hologic, Danaher, Chembio Diagnostics, Natera, and More
News items for the in vitro diagnostics industry for the week of Nov. 29, 2021.
Danaher Prices $1B Offering of Senior Notes
Net proceeds from the offering are expected to be $984 million, which Danaher plans to use to redeem all outstanding 2.5 percent senior notes due in 2025.
Danaher Q3 Revenues Rise 23 Percent, Beat Wall Street Estimates
The firm's revenues were driven by almost a 30 percent increase in the diagnostics segment and almost a 25 percent increase in life sciences.
Apr 22, 2021
Danaher Q1 Revenues Up 58 Percent
Jan 28, 2021
Danaher Q4 Revenues up 39 Percent
Oct 22, 2020
Danaher Q3 Revenues Up 35 Percent
Sep 30, 2020